Miist Therapeutics has developed an innovative inhalation drug delivery system specifically aimed at addressing smoking addiction. This advanced system is designed to provide fast-acting treatment, allowing users to carry it conveniently throughout their daily activities. By enabling patients to continue their habitual smoking behavior while simultaneously addressing their addiction, Miist offers a unique approach to smoking cessation that could significantly improve the chances of successful recovery.

The company emphasizes the importance of their solution in combating the smoking epidemic, which claims over 480,000 lives annually in the U.S. and imposes substantial economic costs. Miist Therapeutics positions its product as a critical tool in the fight against smoking addiction, highlighting its potential to help millions of individuals overcome their dependence on tobacco through a more manageable and effective treatment method.

United States

Miist Therapeutics is a pharmaceutical company focused on developing novel treatments to free people from addiction, starting with smoking. Our initial focus is to eliminate the inordinate amount of death and disease that cigarettes cause by putting an effective quitting aid in every smokers pocket. The majority of US smokers are already trying to quit year after year, they are simply unable to because of today's ineffective treatment options. We are changing that here at Miist and building a future without unwanted addiction.

Miist Therapeutics

Company Details